Eliquis apixaban

Eliquis is a widely recognized prescription medication containing the active ingredient apixaban. It functions as an anticoagulant, commonly referred to as a blood thinner, used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. The drug was developed through a strategic alliance between two major pharmaceutical giants, Bristol Myers Squibb and Pfizer.

Manufacturing of Eliquis is performed at several high-tech pharmaceutical facilities globally to meet international demand. Major production sites are located in the United States, Puerto Rico, and various European countries. The ownership remains a joint venture, with Bristol Myers Squibb (BMS) leading the commercialization and financial reporting aspects while sharing profits and certain development costs with Pfizer. The product shown includes multilingual labeling, indicating it was packaged for a European market.